Complications of Botulinum Toxin Injections: Non-Response, Ptosis, and Dysphagia

Conclusions

• True non-response to botulinum toxin is rare in cosmetic practice and is more often due to technique issues, compensatory muscle use, or tachyphylaxis than to clinically meaningful antibody formation.
• Neutralizing antibodies can cause loss of effect, but binding antibodies are usually not clinically important and even some patients with neutralizing antibodies may still respond.
• Antibody risk appears to rise with higher toxin doses, short injection intervals, booster treatments, and formulations with more complexing or inactive proteins.
• If a patient truly stops responding, the practical approach is to confirm it is real non-response, consider switching toxin brands or serotypes, stop treatment for a washout period, and restart with a lower-protein-load product while avoiding touch-ups.
• Ptosis is largely preventable with careful anatomy review, conservative injection technique, and attention to patients whose brows or eyelids are already low or who have had recent surgery.
• When ptosis occurs, it is usually temporary and can be managed with agents such as oxymetazoline that stimulate Müller’s muscle.
• Platysma injections can improve jawline definition and neck bands, but thin necks and anterior bands increase the risk of diffusion into swallowing muscles.
• Dysphagia, dysphonia, and neck weakness are dose- and depth-related complications of platysma treatment and are more likely with higher doses or injections that are too deep or too medial.
• Injection technique matters: staying superficial where appropriate, pulling the muscle away, staying lateral when needed, and using symmetrical placement helps reduce adverse effects.
• Overall, most botulinum toxin complications are manageable and can often be minimized through patient selection, anatomy-aware dosing, and careful injection technique.